US Stock MarketDetailed Quotes

KROS Keros Therapeutics

Watchlist
  • 18.830
  • +0.400+2.17%
Close Dec 13 16:00 ET
  • 18.640
  • -0.190-1.01%
Post 19:59 ET
762.75MMarket Cap-3.61P/E (TTM)

Keros Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
4,750.00%388K
37K
83K
151K
143K
8K
0
0
0
0
Operating revenue
4,750.00%388K
--37K
--83K
--151K
--143K
--8K
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
36.40%59.05M
22.11%50.48M
24.95%48.57M
55.69%167.69M
38.29%44.2M
78.35%43.29M
51.13%41.34M
61.11%38.87M
40.85%107.71M
28.53%31.96M
Selling and administrative expenses
7.35%9.82M
13.15%9.96M
32.53%10.31M
26.55%34.83M
28.37%9.11M
31.87%9.15M
18.21%8.8M
28.60%7.78M
29.04%27.53M
17.57%7.09M
-General and administrative expense
7.35%9.82M
13.15%9.96M
32.53%10.31M
26.55%34.83M
28.37%9.11M
31.87%9.15M
18.21%8.8M
28.60%7.78M
29.04%27.53M
17.57%7.09M
Research and development costs
44.19%49.23M
24.53%40.52M
23.05%38.26M
55.00%135.26M
50.77%37.49M
62.27%34.14M
39.74%32.53M
71.98%31.09M
58.25%87.27M
32.04%24.87M
Other operating expenses
----
----
----
66.11%-2.4M
----
----
----
----
---7.08M
--0
Operating profit
-35.53%-58.66M
-22.02%-50.44M
-24.73%-48.48M
-55.55%-167.54M
-37.84%-44.06M
-78.32%-43.28M
-51.13%-41.34M
-61.11%-38.87M
-91.06%-107.71M
-556.80%-31.96M
Net non-operating interest income expense
0
75.00%-1K
0
Non-operating interest expense
----
----
----
--0
----
----
----
----
-75.00%1K
--0
Other net income (expense)
48.46%5.7M
35.23%5.18M
75.17%5.37M
380.01%14.55M
70.03%3.81M
403.94%3.84M
4,355.81%3.83M
5,294.92%3.07M
951.40%3.03M
3,129.73%2.24M
Gain on sale of security
48.27%5.79M
34.89%5.38M
86.99%5.81M
304.91%14.76M
--3.76M
--3.91M
--3.99M
--3.11M
13,396.30%3.64M
----
Other non- operating income (expenses)
-37.31%-92K
-26.45%-196K
-992.50%-437K
66.39%-206K
103.99%56K
-108.79%-67K
-280.23%-155K
32.20%-40K
-60.05%-613K
-1,288.12%-1.4M
Income before tax
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.8M
-84.51%-104.68M
-501.46%-29.72M
Income tax
0
0
Net income
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.8M
-78.20%-104.68M
-328.21%-29.72M
Net income continuous Operations
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.8M
-78.20%-104.68M
-328.21%-29.72M
Minority interest income
Net income attributable to the parent company
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.8M
-78.20%-104.68M
-328.21%-29.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.8M
-78.20%-104.68M
-328.21%-29.72M
Basic earnings per share
-6.02%-1.41
1.57%-1.25
3.97%-1.21
-25.30%-5.2
-22.94%-1.34
-44.57%-1.33
-12.39%-1.27
-24.75%-1.26
-64.68%-4.15
-263.33%-1.09
Diluted earnings per share
-6.02%-1.41
1.57%-1.25
3.97%-1.21
-25.30%-5.2
-22.94%-1.34
-44.57%-1.33
-12.39%-1.27
-24.75%-1.26
-64.68%-4.15
-263.33%-1.09
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 4,750.00%388K37K83K151K143K8K0000
Operating revenue 4,750.00%388K--37K--83K--151K--143K--8K--0--0--0--0
Cost of revenue
Gross profit
Operating expense 36.40%59.05M22.11%50.48M24.95%48.57M55.69%167.69M38.29%44.2M78.35%43.29M51.13%41.34M61.11%38.87M40.85%107.71M28.53%31.96M
Selling and administrative expenses 7.35%9.82M13.15%9.96M32.53%10.31M26.55%34.83M28.37%9.11M31.87%9.15M18.21%8.8M28.60%7.78M29.04%27.53M17.57%7.09M
-General and administrative expense 7.35%9.82M13.15%9.96M32.53%10.31M26.55%34.83M28.37%9.11M31.87%9.15M18.21%8.8M28.60%7.78M29.04%27.53M17.57%7.09M
Research and development costs 44.19%49.23M24.53%40.52M23.05%38.26M55.00%135.26M50.77%37.49M62.27%34.14M39.74%32.53M71.98%31.09M58.25%87.27M32.04%24.87M
Other operating expenses ------------66.11%-2.4M-------------------7.08M--0
Operating profit -35.53%-58.66M-22.02%-50.44M-24.73%-48.48M-55.55%-167.54M-37.84%-44.06M-78.32%-43.28M-51.13%-41.34M-61.11%-38.87M-91.06%-107.71M-556.80%-31.96M
Net non-operating interest income expense 075.00%-1K0
Non-operating interest expense --------------0-----------------75.00%1K--0
Other net income (expense) 48.46%5.7M35.23%5.18M75.17%5.37M380.01%14.55M70.03%3.81M403.94%3.84M4,355.81%3.83M5,294.92%3.07M951.40%3.03M3,129.73%2.24M
Gain on sale of security 48.27%5.79M34.89%5.38M86.99%5.81M304.91%14.76M--3.76M--3.91M--3.99M--3.11M13,396.30%3.64M----
Other non- operating income (expenses) -37.31%-92K-26.45%-196K-992.50%-437K66.39%-206K103.99%56K-108.79%-67K-280.23%-155K32.20%-40K-60.05%-613K-1,288.12%-1.4M
Income before tax -34.27%-52.96M-20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M-67.77%-39.44M-37.55%-37.51M-48.04%-35.8M-84.51%-104.68M-501.46%-29.72M
Income tax 00
Net income -34.27%-52.96M-20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M-67.77%-39.44M-37.55%-37.51M-48.04%-35.8M-78.20%-104.68M-328.21%-29.72M
Net income continuous Operations -34.27%-52.96M-20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M-67.77%-39.44M-37.55%-37.51M-48.04%-35.8M-78.20%-104.68M-328.21%-29.72M
Minority interest income
Net income attributable to the parent company -34.27%-52.96M-20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M-67.77%-39.44M-37.55%-37.51M-48.04%-35.8M-78.20%-104.68M-328.21%-29.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -34.27%-52.96M-20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M-67.77%-39.44M-37.55%-37.51M-48.04%-35.8M-78.20%-104.68M-328.21%-29.72M
Basic earnings per share -6.02%-1.411.57%-1.253.97%-1.21-25.30%-5.2-22.94%-1.34-44.57%-1.33-12.39%-1.27-24.75%-1.26-64.68%-4.15-263.33%-1.09
Diluted earnings per share -6.02%-1.411.57%-1.253.97%-1.21-25.30%-5.2-22.94%-1.34-44.57%-1.33-12.39%-1.27-24.75%-1.26-64.68%-4.15-263.33%-1.09
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List